Cargando…

Determination of risk factors for drug-related problems: a multidisciplinary triangulation process

INTRODUCTION AND OBJECTIVES: Drug-related problems (DRPs) constitute a frequent safety issue among hospitalised patients leading to patient harm and increased healthcare costs. Because many DRPs are preventable, the specific risk factors that facilitate their occurrence are of considerable interest....

Descripción completa

Detalles Bibliográficos
Autores principales: Kaufmann, Carole P, Stämpfli, Dominik, Hersberger, Kurt E, Lampert, Markus L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368979/
https://www.ncbi.nlm.nih.gov/pubmed/25795686
http://dx.doi.org/10.1136/bmjopen-2014-006376
_version_ 1782362716051079168
author Kaufmann, Carole P
Stämpfli, Dominik
Hersberger, Kurt E
Lampert, Markus L
author_facet Kaufmann, Carole P
Stämpfli, Dominik
Hersberger, Kurt E
Lampert, Markus L
author_sort Kaufmann, Carole P
collection PubMed
description INTRODUCTION AND OBJECTIVES: Drug-related problems (DRPs) constitute a frequent safety issue among hospitalised patients leading to patient harm and increased healthcare costs. Because many DRPs are preventable, the specific risk factors that facilitate their occurrence are of considerable interest. The objective of our study was to assess risk factors for the occurrence of DRPs with the intention to identify patients at risk for DRPs to guide and target preventive measures where they are needed most in patients. DESIGN: Triangulation process using a mixed methods approach. METHODS: We conducted an expert panel, using the nominal group technique (NGT) and a qualitative analysis, to gather risk factors for DRPs. The expert panel consisted of two consultant hospital physicians (internal medicine and geriatrics), one emergency physician, one independent general practitioner, one clinical pharmacologist, one clinical pharmacist, one registered nurse, one home care nurse and two independent community pharmacists. The literature was searched for additional risk factors. Gathered factors from the literature search and the NGT were assembled and validated in a two-round Delphi questionnaire. RESULTS: The NGT resulted in the identification of 33 items with 13 additional risk factors from the qualitative analysis of the discussion. The literature search delivered another 39 risk factors. The 85 risk factors were refined to produce 42 statements for the Delphi online questionnaire. Of these, 27 risk factors were judged to be ‘important’ or ‘rather important’. CONCLUSIONS: The gathered risk factors may help to characterise and identify patients at risk for DRPs and may enable clinical pharmacists to guide and target preventive measures in order to limit the occurrence of DRPs. As a further step, these risk factors will serve as the basis for a screening tool to identify patients at risk for DRPs.
format Online
Article
Text
id pubmed-4368979
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-43689792015-03-26 Determination of risk factors for drug-related problems: a multidisciplinary triangulation process Kaufmann, Carole P Stämpfli, Dominik Hersberger, Kurt E Lampert, Markus L BMJ Open Pharmacology and Therapeutics INTRODUCTION AND OBJECTIVES: Drug-related problems (DRPs) constitute a frequent safety issue among hospitalised patients leading to patient harm and increased healthcare costs. Because many DRPs are preventable, the specific risk factors that facilitate their occurrence are of considerable interest. The objective of our study was to assess risk factors for the occurrence of DRPs with the intention to identify patients at risk for DRPs to guide and target preventive measures where they are needed most in patients. DESIGN: Triangulation process using a mixed methods approach. METHODS: We conducted an expert panel, using the nominal group technique (NGT) and a qualitative analysis, to gather risk factors for DRPs. The expert panel consisted of two consultant hospital physicians (internal medicine and geriatrics), one emergency physician, one independent general practitioner, one clinical pharmacologist, one clinical pharmacist, one registered nurse, one home care nurse and two independent community pharmacists. The literature was searched for additional risk factors. Gathered factors from the literature search and the NGT were assembled and validated in a two-round Delphi questionnaire. RESULTS: The NGT resulted in the identification of 33 items with 13 additional risk factors from the qualitative analysis of the discussion. The literature search delivered another 39 risk factors. The 85 risk factors were refined to produce 42 statements for the Delphi online questionnaire. Of these, 27 risk factors were judged to be ‘important’ or ‘rather important’. CONCLUSIONS: The gathered risk factors may help to characterise and identify patients at risk for DRPs and may enable clinical pharmacists to guide and target preventive measures in order to limit the occurrence of DRPs. As a further step, these risk factors will serve as the basis for a screening tool to identify patients at risk for DRPs. BMJ Publishing Group 2015-03-20 /pmc/articles/PMC4368979/ /pubmed/25795686 http://dx.doi.org/10.1136/bmjopen-2014-006376 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Pharmacology and Therapeutics
Kaufmann, Carole P
Stämpfli, Dominik
Hersberger, Kurt E
Lampert, Markus L
Determination of risk factors for drug-related problems: a multidisciplinary triangulation process
title Determination of risk factors for drug-related problems: a multidisciplinary triangulation process
title_full Determination of risk factors for drug-related problems: a multidisciplinary triangulation process
title_fullStr Determination of risk factors for drug-related problems: a multidisciplinary triangulation process
title_full_unstemmed Determination of risk factors for drug-related problems: a multidisciplinary triangulation process
title_short Determination of risk factors for drug-related problems: a multidisciplinary triangulation process
title_sort determination of risk factors for drug-related problems: a multidisciplinary triangulation process
topic Pharmacology and Therapeutics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368979/
https://www.ncbi.nlm.nih.gov/pubmed/25795686
http://dx.doi.org/10.1136/bmjopen-2014-006376
work_keys_str_mv AT kaufmanncarolep determinationofriskfactorsfordrugrelatedproblemsamultidisciplinarytriangulationprocess
AT stampflidominik determinationofriskfactorsfordrugrelatedproblemsamultidisciplinarytriangulationprocess
AT hersbergerkurte determinationofriskfactorsfordrugrelatedproblemsamultidisciplinarytriangulationprocess
AT lampertmarkusl determinationofriskfactorsfordrugrelatedproblemsamultidisciplinarytriangulationprocess